Cargando…

Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer

PURPOSE: Topoisomerase-II alpha (TopoIIA ), a DNA gyrase isoform that plays an important role in the cell cycle, is present in normal tissues and various human cancers, and can show altered expression in both. The aim of the current study was to examine the value of urinary TopoIIA cell-free DNA as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ye-Hwan, Yan, Chunri, Lee, Il-Seok, Piao, Xuan-Mei, Byun, Young Joon, Jeong, Pildu, Kim, Won Tae, Yun, Seok-Joong, Kim, Wun-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791669/ https://www.ncbi.nlm.nih.gov/pubmed/26981592 http://dx.doi.org/10.4111/icu.2016.57.2.106

Ejemplares similares

Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls
por: Kim, Won Tae, et al.
Publicado: (2016)

UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria
por: Kim, Won Tae, et al.
Publicado: (2016)

Diagnosis of bladder cancer and prediction of survival by urinary metabolomics
por: Jin, Xing, et al.
Publicado: (2014)

GSTM1 Tissue Genotype as a Recurrence Predictor in Non-muscle Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2011)

A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer
por: Piao, Xuan-Mei, et al.
Publicado: (2020)

Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer
por: Yan, Chunri, et al.
Publicado: (2015)

Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer
por: Kim, Won Tae, et al.
Publicado: (2018)

Prominence of urinary biomarkers for bladder cancer in the COVID-19 era: From the commercially available to new prospective candidates
por: Piao, Xuan-Mei, et al.
Publicado: (2021)

GSTT1 as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ha, Yun-Sok, et al.
Publicado: (2010)

CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer
por: Kim, Ye-Hwan, et al.
Publicado: (2018)

Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer
por: Lee, Jong-Young, et al.
Publicado: (2018)

Unmasking molecular profiles of bladder cancer
por: Piao, Xuan-Mei, et al.
Publicado: (2018)

Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer
por: Byun, Young Joon, et al.
Publicado: (2021)

Granular Cell Tumor of the Urinary Bladder
por: Kang, Ho-Won, et al.
Publicado: (2010)

Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis
por: Jeong, Pildu, et al.
Publicado: (2015)

Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker
por: Piao, Xuan-Mei, et al.
Publicado: (2021)

A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy
por: Kim, Seon-Kyu, et al.
Publicado: (2021)

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
por: Kang, Ho Won, et al.
Publicado: (2020)

Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression
por: Piao, Xuan-Mei, et al.
Publicado: (2021)

Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2
por: Kim, Ye-Hwan, et al.
Publicado: (2014)

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
por: Kim, Wun-Jae, et al.
Publicado: (2010)

Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
por: Yun, Seok Joong, et al.
Publicado: (2015)

Impact of Transobturator Tape Treatment on Overactive Bladder Symptoms, Particularly Nocturia, in Patients With Mixed Urinary Incontinence
por: Lee, Sang Keun, et al.
Publicado: (2014)

The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease
por: Kim, Young-Won, et al.
Publicado: (2015)

Parathyroid hormone is associated with prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2020)

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
por: Piao, Xuan-Mei, et al.
Publicado: (2022)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)

The role of DNA bending in type IIA topoisomerase function
por: Lee, Imsang, et al.
Publicado: (2013)

Viral origin of eukaryotic type IIA DNA topoisomerases
por: Guglielmini, Julien, et al.
Publicado: (2022)

Generation of Whole-Genome Sequencing Data for Comparing Primary and Castration-Resistant Prostate Cancer
por: Park, Jong-Lyul, et al.
Publicado: (2018)

Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer
por: Lee, Il-Seok, et al.
Publicado: (2017)

Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma
por: Kang, Ho Won, et al.
Publicado: (2019)

Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone
por: Kang, Ho Won, et al.
Publicado: (2022)

How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
por: Yun, Seok Joong, et al.
Publicado: (2016)

Forkhead box O-class 1 and Forkhead box G1 as Prognostic Markers for Bladder Cancer
por: Kim, Tae-Hwan, et al.
Publicado: (2009)

Tumor heterogeneity in muscle-invasive bladder cancer
por: Kang, Ho Won, et al.
Publicado: (2020)

Identification of Pro-Inflammatory Cytokines Associated with Muscle Invasive Bladder Cancer; The Roles of IL-5, IL-20, and IL-28A
por: Lee, Se-Jung, et al.
Publicado: (2012)

Theoretical models of DNA topology simplification by type IIA DNA topoisomerases
por: Vologodskii, Alexander
Publicado: (2009)

Expression of hsv1-miR-H18 and hsv2-miR-H9 as a field defect marker for detecting prostate cancer
por: Byun, Young Joon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bfqh9gdpo9fhq0f121dbn5t20n